Latest Elective cosmetic procedures News

AbbVie makes $63B bid for Botox maker Allergan

Jun. 25, 2019 2:39 PM EDT

Facing competition for the world's top-selling drug, AbbVie is jumping on this year's pharmaceutical merger bandwagon with a $63 billion bid for Botox maker Allergan that's meant to spur future growth. Specialty drugmaker AbbVie said Tuesday that adding Allergan's aesthetics products and eye care and other...